PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31

PRECIGEN, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$6.66+0.28 (+4.31%)

Close on Oct 19, 2026

Market cap: $2.76B
P/E (TTM): –
Dividend yield: –

PRECIGEN, INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31	Q3 2016 2016-09-30
Cash & Equivalents	16	7.48	30	14	14	6.06	30	25	9.61	18	7.85	10	17	24	49	92	50	41	43	42	37	28	52	28	47	38	68	45	59	107	110	90	86	127	76	72	72	77	70	70
Short-Term Investments	22	49	68	107	46	74	68	3.91	10	27	55	64	72	94	51	62	71	72	72	73	79	78	48	85	86	111	9.26	45	68	75	120	164	0.35	0.28	6.27	45	93	135	175	167
Cash & Short-Term Investments	39	57	100	124	60	81	98	29	20	45	63	74	89	118	100	154	121	113	116	115	116	106	101	114	133	150	78	90	126	182	222	254	86	128	82	116	165	212	244	237
Receivables	72	26	3.92	0.58	0.33	0.75	0.93	0.48	0.51	0.87	0.90	0.99	1.35	1.77	0.98	1.18	1.31	24	1.34	20	26	21	16	19	23	19	21	20	24	20	21	18	23	18	20	18	23	20	22	22
Prepaid Expenses & Other	3.89	4.00	3.43	4.30	2.43	3.30	3.34	5.15	3.16	3.63	4.33	5.13	2.79	4.33	5.07	6.36	2.65	5.20	5.47	7.66	3.48	6.43	7.19	8.31	3.27	5.60	5.83	9.03	4.71	5.58	5.33	7.59	5.80	6.07	7.06	8.05	7.18	7.17	7.36	8.59
Total Current Assets	134	102	115	130	63	85	102	35	24	50	69	93	106	138	118	163	165	155	157	153	157	144	149	151	173	189	235	157	183	232	285	310	148	188	154	180	234	282	315	316
Property, Plant & Equipment	13	13	14	15	15	15	14	14	13	13	7.11	7.12	6.57	6.91	7.33	7.61	7.73	34	8.60	33	33	34	35	45	47	60	44	123	120	136	87	123	119	119	113	103	93	68	65	54
Gross Property, Plant & Equipment	38	38	38	38	37	38	37	36	36	37	31	31	31	31	31	30	30	74	30	71	71	70	70	98	99	109	80	181	181	195	136	176	171	168	158	145	132	105	99	87
Accumulated Depreciation	-25	-25	-24	-23	-23	-23	-23	-23	-22	-25	-24	-24	-24	-24	-23	-23	-22	-40	-21	-39	-38	-36	-35	-53	-52	-49	-36	-58	-61	-59	-49	-53	-51	-49	-46	-43	-40	-37	-34	-32
Buildings & Improvements	2.63	2.63	2.63	2.63	2.63	2.63	2.63	2.63	2.63	2.63	2.63	2.63	2.63	2.59	2.59	2.59	2.59	13	2.59	12	12	12	12	12	12	12	12	12	12	20	20	19	18	18	18	15	15	8.13	8.12	7.97
Machinery & Equipment	20	20	19	19	17	17	17	17	17	19	19	18	19	18	18	18	18	34	17	33	32	32	31	48	47	52	34	67	68	77	64	72	70	70	66	59	57	46	44	41
Construction in Progress	0.33	0.28	0.28	0.26	10	10	9.02	8.38	8.11	7.31	1.58	0.89	0.11	0.15	0.53	1.24	1.06	3.60	1.83	2.73	2.19	2.53	2.75	3.67	4.80	5.38	5.23	26	23	24	10	19	17	16	14	15	12	7.16	4.51	7.52
Long-Term Investments	0.49	0.49	2.51	2.51	–	0.75	0	–	–	–	–	5.27	7.13	7.46	0	0	12	30	49	67	85	104	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Equity Method Investments	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0.34	0.86	1.11	1.46	17	18	18	2.14	18	20	21	19	23	22	24	24	26
Operating Lease Right-of-Use Assets	4.14	4.37	4.68	4.86	4.81	5.07	5.06	5.31	5.55	6.66	7.10	7.20	7.62	7.62	8.09	8.83	8.94	11	9.99	12	12	8.64	9.35	19	21	24	12	43	42	43	0	–	–	–	–	–	–	–	–	–
Goodwill	15	15	15	15	15	19	19	25	25	27	27	37	37	37	37	37	37	54	38	54	54	54	54	54	54	64	54	148	150	151	94	151	152	155	94	167	165	158	157	160
Intangible Assets	2.55	2.86	3.18	3.50	3.82	4.14	4.46	4.77	5.09	39	41	40	43	44	44	42	46	51	52	57	60	61	65	65	65	65	68	107	113	126	89	213	219	232	233	241	240	223	226	239
Other Long-Term Assets	0.71	0.78	0.91	0.75	0.59	0.43	0.37	0.43	0.44	0.75	0.77	0.80	0.95	1.00	1.03	0.87	0.92	1.13	0.94	1.24	1.33	1.43	1.60	1.50	1.34	1.33	1.35	2.56	8.03	2.38	2.07	2.37	3.60	4.03	4.05	9.84	11	4.94	3.71	3.49
Total Assets	170	139	156	171	102	129	145	83	73	135	151	191	208	242	216	259	321	336	360	377	403	407	315	336	362	405	456	605	655	710	716	980	825	896	847	898	934	916	949	1,006
Accounts Payable	5.30	2.59	12	6.26	3.92	3.11	3.53	4.32	4.85	4.72	1.73	2.35	2.51	3.81	4.07	4.20	2.67	4.42	3.11	3.62	4.94	4.30	4.60	4.23	3.65	4.78	5.53	7.40	8.56	13	12	8.52	8.44	7.84	8.70	7.85	8.22	7.95	8.48	7.87
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	0	0	0	14	43	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Portion of Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	43	82	0	0.36	0.05	0.36	0.36	0.36	0.36	0.42	32	32	32	31	0.47	0.56	0.48	0.55	0.49	0.50	0.50	0.44	0.43	0.39	0.39	0.47
Current Debt	–	–	–	–	–	–	–	–	–	–	0	0	0	14	86	82	0	0.36	0.05	0.36	0.36	0.36	0.36	0.42	32	32	32	31	0.47	0.56	0.48	0.55	0.49	0.50	0.50	0.44	0.43	0.39	0.39	0.47
Current Portion of Leases	1.06	1.07	1.14	1.12	0.93	0.93	0.96	0.99	1.27	1.32	1.20	1.20	1.42	1.24	1.21	1.04	1.03	1.59	1.39	1.96	1.94	2.66	2.66	4.58	4.51	4.31	2.63	6.22	4.81	4.78	0	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	0.28	0.41	0.52	0.48	0.41	0.55	0.59	0.41	0.38	0.41	0.51	0.51	0.02	0.02	0.03	0.08	0.16	2.67	1.49	3.69	3.28	3.85	2.80	4.14	6.59	11	5.70	13	17	17	11	38	40	38	43	48	48	50	53	55
Total Current Liabilities	29	21	37	32	23	24	22	21	23	29	23	33	31	47	79	105	30	26	35	29	29	25	42	31	64	71	123	82	52	59	62	92	83	77	80	88	96	91	95	101
Long-Term Debt	94	94	93	–	–	–	0	–	–	–	–	–	–	–	0	0	199	201	180	180	177	174	172	194	191	189	186	184	212	214	211	183	7.27	7.43	7.54	7.67	7.68	7.61	7.56	7.95
Long-Term Leases	3.41	3.66	3.98	4.18	4.22	4.49	4.55	4.76	5.07	5.39	5.90	6.19	6.55	6.62	6.99	7.94	8.10	9.51	8.75	11	12	6.94	7.74	20	21	22	10	38	39	40	0	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	4.47	4.73	5.12	5.30	5.15	5.42	5.50	5.75	6.34	6.71	7.10	7.39	7.97	7.87	8.20	8.98	9.13	11	11	13	14	9.60	10	25	26	27	28	44	44	45	0	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	–	–	0	0.09	0.08	1.78	1.85	2.13	2.18	2.24	2.26	2.09	2.26	2.44	2.54	2.57	2.69	2.72	2.90	2.73	2.70	2.79	2.83	5.73	6.33	6.72	3.86	9.36	10	12	16	16	16	17	17	18
Other Long-Term Liabilities	0.08	0.11	0.13	0.16	–	–	0	–	–	–	–	–	–	–	–	–	–	0.05	0.05	0.05	0.05	0.10	0.10	0.10	0.10	–	0	0.22	0.22	0.66	3.14	3.20	3.17	3.59	3.45	5.75	5.14	4.05	3.87	3.18
Total Liabilities	127	118	135	129	108	113	79	28	30	38	33	43	41	57	90	117	266	262	253	246	243	232	247	278	312	317	384	376	376	375	337	425	258	262	300	345	362	366	380	397
Total Debt	94	94	93	–	–	–	0	–	–	–	0	0	0	14	86	82	199	201	180	180	177	175	172	194	223	221	218	215	213	215	212	184	7.76	7.93	8.04	8.11	8.12	8.00	7.95	8.42
Additional Paid-In Capital	2,373	2,370	2,362	2,360	2,135	2,131	2,129	2,126	2,093	2,088	2,085	2,083	2,080	2,078	1,998	1,996	1,994	1,992	2,023	2,020	2,017	2,014	1,887	1,839	1,802	1,797	1,752	1,745	1,737	1,733	1,722	1,552	1,504	1,493	1,397	1,371	1,356	1,324	1,326	1,311
Retained Earnings	-2,329	-2,349	-2,341	-2,318	-2,172	-2,145	-2,091	-2,071	-2,047	-1,988	-1,964	-1,931	-1,912	-1,891	-1,869	-1,846	-1,934	-1,916	-1,916	-1,891	-1,861	-1,841	-1,823	-1,782	-1,752	-1,709	-1,653	-1,484	-1,430	-1,391	-1,331	-990	-933	-867	-848	-821	-781	-762	-729	-685
Comprehensive Income & Other	-0.03	-0.02	0.01	0.02	0.01	0.01	0.01	0.01	-2.91	-2.80	-1.95	-3.56	-2.52	-2.70	-3.49	-7.18	-4.56	-1.70	0.20	1.52	2.54	1.75	4.00	1.36	-0.65	-1.35	-27	-33	-28	-28	-29	-23	-22	-9.74	-16	-17	-24	-33	-36	-25
Shareholders' Equity	44	20	21	42	-37	-14	39	55	43	97	118	148	166	184	126	143	56	74	107	131	159	175	67	59	50	87	72	228	279	313	363	539	550	616	534	534	551	529	560	600
Noncontrolling Interest	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	22	16	16	17	18	13	20	21	22	9.01	7.95
Total Equity	44	20	21	42	-37	-14	39	55	43	97	118	148	166	184	126	143	56	74	107	131	159	175	67	59	50	87	72	228	279	335	379	555	567	634	547	553	572	550	569	608
Total Liabilities & Equity	170	139	156	171	102	129	145	83	73	135	151	191	208	242	216	259	321	336	360	377	403	407	315	336	362	405	456	605	655	710	716	980	825	896	847	898	934	916	949	1,006
Shares Outstanding(shares)	358	356	354	354	298	295	293	293	253	250	249	256	255	255	208	208	208	208	207	207	207	206	188	179	172	171	163	163	162	161	160	137	129	129	122	121	120	120	119	118

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: -1141.1%
Net margin: -1628.5%
Return on equity, FY2025: -843.6%

Financial strength

Current ratio: 4.58
Debt to equity: 2.15
Debt to assets: 55.1%
Cash to current liabilities: 55.6%

Valuation

P/E ratio: –
Price to sales: 284.51
Price to book: 63.23
Dividend yield: –